google
The report "Global Cancer Therapy Market, By Cancer Type (Breast Cancer, Prostate Cancer, Blood Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Gynecologic Cancer, and Other Cancer Types), By Treatment Type (Immunotherapy, Hormonal Therapy, Chemotherapy, Targeted Therapy, and Other Treatment Types), By End User (Cancer and Radiation Therapy Centers, Hospitals, and Specialty Clinics), and Region - Global Forecast to 2030" global cancer therapy market is projected to grow from US$ 66.5 billion in 2019 Certain factors that are driving the market growth include increasing Patient Assistance Programs (PAPs), increasing government initiatives for cancer awareness, rising prevalence of cancer worldwide, and strong R&D initiatives from key players. The upsurge in demand for personalized medicine and high potential of developing nations is expected to provide new opportunities for the market players in future.
Key Highlights:
- In January 2020, Medtronic Launches Efficio software to help clinicians efficiently manage targeted drug delivery therapy with SynchroMed
- In January 2020, Roche announced the completion of a supplemental Biologics License Application (sBLA) submission to the US Food and Drug Administration (FDA) for Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab), for the treatment of people with unresectable hepatocellular carcinoma (HCC) who have not received prior systemic therapy.
Key Market Insights from the report:
The global cancer therapy market accounted for US$ 66.5 billion in 2019 and is projected to register a moderate CAGR of 8.50% over the forecast period. The market report has been segmented on the cancer type, treatment type, end user, and region.
- By cancer type, breast cancer is expected to dominate in this segment, due to higher and continuously increasing prevalence of breast cancer across the world.
- By treatment type, the target therapy segment is dominating in this segment, due to its specificity toward cancer cells, while sparing the toxicity to off-target cells.
- By end user, the global cancer therapy market is sub-divided into cancer and radiation therapy centers, hospitals, and specialty clinics.
- By region, North America is projected to lead the global cancer therapy market and is expected to remain dominant during the forecast period, owing to the increased adoption of cancer therapy.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on " Global Cancer Therapy Market”, By Cancer Type (Breast Cancer, Prostate Cancer, Blood Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Gynecologic Cancer, and Other Cancer Types), By Treatment Type (Immunotherapy, Hormonal Therapy, Chemotherapy, Targeted Therapy, and Other Treatment Types), By End User (Cancer and Radiation Therapy Centers, Hospitals, and Specialty Clinics), and by Region – global forecast till 2030
To know the upcoming trends and insights prevalent in this market, click the link below:
Links: https://prophecymarketinsights.com/market_insight/Global-Cancer-Therapy-Market-By-3768
Sales
Prophecy Market Insights
Email- [email protected]
0
google
Related Articles
Radiation therapy utilizes high-energy beams to kill cancer cells or slow their growth, while chemotherapy employs anticancer drugs to destroy cancer cells. Hormone therapy hinders or blocks the effects of hormones that may contribute to cancer growth. The global Cancer Therapy Market is estimated to be valued at US$ 201103. The cancer therapy market can be segmented based on therapy type into chemotherapy, targeted therapy, immunotherapy, and others. Regional analysis: North America accounted for the largest share of the cancer therapy market in 2022.
0
The global Cancer Therapy Market is estimated to be valued at US$ 231671. If approved, these novel drug candidates are expected to get adopted at a larger scale, thereby propelling the market growth during the forecast period. Segment Analysis The global cancer therapy market is dominated by chemotherapy sub segment accounting for around 30% share of the total market. Regional analysis: North America dominates the global cancer therapy market and is anticipated to maintain its leading position during the forecast period as well. Higher adoption of advanced cancer therapies along with presence of well-established healthcare industry and favorable reimbursement policies are some factors driving the cancer therapy market growth in the region.
0
The Gastric Cancer Therapy Market was estimated to be worth USD 7. Also referred to as stomach cancer, gastric cancer is a kind of cancer that begins in the stomach's lining cells. By End User Ambulatory Surgery Centers Hospitals and Specialty ClinicsOthersBy Therapy TypeChemotherapy Targeted Therapy ImmunotherapyRadiation TherapySurgeryFrequently Asked Questions1. license=single About We Market Research:WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis.
0
The Cancer Therapy Market is estimated to be valued at US$ 171,143. Segment Analysis: The Cancer Therapy Market Size can be segmented based on therapy type, cancer type, and end-user. PEST Analysis: Political: Government initiatives and policies play a crucial role in shaping the cancer therapy market. Key Takeaways: The global cancer therapy market is expected to witness high growth, exhibiting a CAGR of 8. In terms of regional analysis, North America is the fastest-growing and dominating region in the cancer therapy market.
0
The cancer therapy market is a dynamic and rapidly evolving sector that plays a crucial role in combating cancer, one of the leading causes of death worldwide. This blog provides a comprehensive overview of the cancer therapy market, highlighting key components and recent trends. The cancer therapy market encompasses a wide range of treatments designed to target and eliminate cancer cells while minimizing damage to healthy tissues. Increasing incidence of cancer around the world is expected to augment the growth of the global Cancer Therapy Market over the forecast period. Chemotherapy uses drugs to kill cancer cells, while radiation therapy uses high-energy beams to kill cancer cells.
0
The global cancer therapy market offers various advantages such as targeted cancer treatment with minimal side effects and improved survival and recovery rate of cancer patients. The global Cancer Therapy Market is estimated to be valued at US$ 201103. As personalized cancer treatment helps in targeting the exact cancer mutation in a patient with minimal side effects, it provides improved outcomes. With advancements in precision medicine and biomarker development, personalized cancer treatment is expected to revolutionize cancer care and significantly contribute to the growth of the cancer therapy market during the forecast period. Key Takeaways The Global Cancer Therapy Market Size is expected to witness high growth over the forecast period till 2030.
0
